Non-monotonic dose-response relationships and endocrine disruptors: A qualitative method of assessment -No section-

Environmental Health: A Global Access Science Source

Volumn 14, Issue 1, 2015, Pages

  Lagarde, Fabien ^a   Beausoleil, Claire ^a   Belcher, Scott M ^b   Belzunces, Luc P ^c   Emond, Claude ^d   Guerbet, Michel ^e   Rousselle, Christophe ^a  

^a FRENCH AGENCY FOR FOOD   (France)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Laboratoire de Toxicologie Environnementale   (France)

^d BioSimulation Consulting Inc   (United States)

^e UNIVERSITÉ DE ROUEN   (France)

Author keywords

Bisphenol A; Dose response; Endocrine disruptors; NMDR; Non monotonic; Risk assessment

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALKYLPHENOL; DIETHYLHEXYLPHTHALATE; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; HORMONE; PESTICIDE; PHYTOESTROGEN; POLYCHLORINATED BIPHENYL; UNCLASSIFIED DRUG; POLLUTANT;

DECISION SUPPORT SYSTEM; DOSE-RESPONSE RELATIONSHIP; ENDOCRINE DISRUPTOR; EXPERIMENTAL STUDY; IDENTIFICATION METHOD; LITERATURE REVIEW; PHYSIOLOGICAL RESPONSE; QUALITATIVE ANALYSIS; RISK ASSESSMENT;

DECISION TREE; DOSE RESPONSE; HORMESIS; NEGATIVE FEEDBACK; NON MONOTONIC DOSE RESPONSE RELATIONSHIP; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RECEPTOR DOWN REGULATION; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TOXICOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; POLLUTANT; PROCEDURES; TOXICITY;

DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; RISK ASSESSMENT;

EID: 84929008164     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-14-13     Document Type: Review

References (83)

1. Birnbaum LS: Environmental chemicals: evaluating low-dose effects. Environ Health Perspect 2012, 120:143-4. 10.1289/ehp.1205179
2. EFSA: EFSA's 17th Scientific Colloquium on low dose response in toxicology and risk assessment: 14-15 June 2012. Parma; [ http://www.efsa.europa.eu/fr/supporting/doc/353e.pdf ]
3. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al.: Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol 2013, 38:1-15.
4. National Research Council (NRC): Risk Assessment in the Federal Government: Managing the Process. Washington, DC: The National Academies Press; 1983.
5. Slob W, Pieters MN: A probabilistic approach for deriving acceptable human intake limits and human risks from toxicological studies: general framework. Risk Anal 1998, 18:787-98. 10.1111/j.1539-6924.1998.tb01121.x
6. Belcher SM, Chen Y, Yan S, Wang HS: Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17beta-estradiol and the environmental endocrine disruptor bisphenol A. Endocrinology 2012, 153:712-20. 10.1210/en.2011-1772
7. Kendig EL, Le HH, Belcher SM: Defining hormesis: evaluation of a complex concentration response phenomenon. Int J Toxicol 2010, 29:235-46. 10.1177/1091581810363012
8. Kohn MC, Melnick RL: Biochemical origins of the non-monotonic receptor-mediated dose-response. J Mol Endocrinol 2002,29(1):113-23. 10.1677/jme.0.0290113
9. WHO-UNEP: State of the Science of Endocrine Disrupting Chemicals. In An assessment of the state of the science of endocrine disruptors prepared by a group of experts Edited by: Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT. 2012. Available at: < > (last accessed (02.02.15). ISBN ISBN: 978-92-807-3274-0. http://www.who.int/ceh/publications/endocrine/en/index.html
10. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al.: Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose-responses. Endocr Rev 2012, 33:378-455. 10.1210/er.2011-1050
11. Wong JK, Le HH, Zsarnovszky A, Belcher SM: Estrogens and ICI182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogenactivated protein kinase. J Neurosci 2003, 23:4984-95.
12. Calabrese EJ, Baldwin L: A quantitatively-based methodology for evaluation of chemical hormesis. Hum Ecol Risk Assess 1997,3(4):545-54. 10.1080/10807039709383710
13. Klimisch HJ, Andreae M, Tillmann U: A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol 1997, 25:1-5. 10.1006/rtph.1996.1076
14. Calabrese EJ, Blain RB: The hormesis database: the occurrence of hormetic dose responses in the toxicological literature. Regul. Toxicol Pharmacol. 2011,61(1):73-81. 10.1016/j.yrtph.2011.06.003
15. Tuomisto J, Pekkanen J, Kiviranta H, Tukiainen E, Vartiainen T, Viluksela M, et al.: Dioxin Cancer Risk - Example of Hormesis? Dose-response 2005, 3:332-41. 10.2203/dose-response.003.03.004
16. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, Jacobs DR Jr: Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One 2011, 6:e15977. 10.1371/journal.pone.0015977
17. Amara JF, Dannies PS: 17 beta-Estradiol has a biphasic effect on gh cell growth. Endocrinology 1983, 112:1141-3. 10.1210/endo-112-3-1141
18. Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, Fenichel P: Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 2009, 117:1053-8. 10.1289/ehp.0800367
19. Castel H, Louiset E, Anouar Y, Le Foll F, Cazin L, Vaudry H: Regulation of GABAA receptor by protein tyrosine kinases in frog pituitary melanotrophs. J Neuroendocrinol 2000, 12:41-52.
20. Christian M, Gillies G: Developing hypothalamic dopaminergic neurones as potential targets for environmental estrogens. J Endocrinol 1999, 160:1-6. 10.1677/joe.0.1600001
21. Devidze N, Fujimori K, Urade Y, Pfaff DW, Mong JA: Estradiol regulation of lipocalin-type prostaglandin D synthase promoter activity: evidence for direct and indirect mechanisms. Neurosci Lett 2010, 474:17-21. 10.1016/j.neulet.2010.02.064
22. Emons G, Ortmann O, Thiessen S, Knuppen R: Effects of estradiol and some antiestrogens (clomiphene, tamoxifen, and hydroxytamoxifen) on luteinizing hormone secretion by rat pituitary cells in culture. Arch Gynecol 1986, 237:199-211. 10.1007/BF02133782
23. Gregoraszczuk EL, Milczarek K, Wojtowicz AK, Berg V, Skaare JU, Ropstad E: Steroid secretion following exposure of ovarian follicular cells to three different natural mixtures of persistent organic pollutants (POPs). Reprod Toxicol 2008, 25:58-66. 10.1016/j.reprotox.2007.10.001
24. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N: Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008, 116:1642-7. 10.1289/ehp.11537
25. Incerpi S, D'Arezzo S, Marino M, Musanti R, Pallottini V, Pascolini A, et al.: Short-term activation by low 17beta-estradiol concentrations of the Na+/H+ exchanger in rat aortic smooth muscle cells: physiopathological implications. Endocrinology 2003, 144:4315-24. 10.1210/en.2003-0495
26. Jeng YJ, Kochukov MY, Watson CS: Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J Mol Signal 2009, 4:2.
27. Jeng YJ, Kochukov M, Watson CS: Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells. Environ Health 2010, 9:61. 10.1186/1476-069X-9-61
28. Kochukov MY, Jeng Y, Watson CS: Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomammotropes. Environ Health Perspect 2009, 117:723-30. 10.1289/ehp.0800182
29. Narita S, Goldblum RM, Watson CS, Brooks EG, Estes DM, Curran EM, et al.: Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect 2007, 115:48-52.
30. Sargis RM, Johnson DN, Choudhury RA, Brady MJ: Environmental endocrine disruptors promote adipogenesis in the 3 T3-L1 cell line through glucocorticoid receptor activation. Obesity 2010, 18:1283-8. 10.1038/oby.2009.419
31. Sonnenschein C, Olea N, Pasanen ME, Soto AM: Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res 1989, 49:3474-81.
32. Wellejus A, Bornholdt J, Vogel UB, Risom L, Wiger R, Loft S: Cell-specific oxidative DNA damage induced by estrogen in rat testicular cells in vitro. Toxicol Lett 2004, 150:317-23. 10.1016/j.toxlet.2004.02.010
33. Wetherill YB, Petre CE, Monk KR, Puga A, Knudsen KE: The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Mol Cancer Ther 2002, 1:515-24.
34. Wozniak AL, Bulayeva NN, Watson CS: Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 2005, 113:431-9. 10.1289/ehp.7505
35. 2+ -ATPase activity. Biochim Biophys Acta 1999, 1437:257-64. 10.1016/S1388-1981(99)00015-3
36. Adewale HB, Jefferson WN, Newbold RR, Patisaul HB: Neonatal bisphenol-a exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin-releasing hormone neurons. Biol Reprod 2009, 81:690-9. 10.1095/biolreprod.109.078261
37. Adewale HB, Todd KL, Mickens JA, Patisaul HB: The impact of neonatal bisphenol-A exposure on sexually dimorphic hypothalamic nuclei in the female rat. Neurotoxicology 2011, 32:38-49. 10.1016/j.neuro.2010.07.008
38. Andrade AJ, Grande SW, Talsness CE, Grote K, Chahoud I: A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl)-phthalate (DEHP): non-monotonic dose-response and low dose effects on rat brain aromatase activity. Toxicology 2006, 227:185-92. 10.1016/j.tox.2006.07.022
39. Ayyanan A, Laribi O, Schuepbach-Mallepell S, Schrick C, Gutierrez M, Tanos T, et al.: Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. Mol Endocrinol 2011, 25:1915-23. 10.1210/me.2011-1129
40. Berger RG, Foster WG, deCatanzaro D: Bisphenol-A exposure during the period of blastocyst implantation alters uterine morphology and perturbs measures of estrogen and progesterone receptor expression in mice. Reprod Toxicol 2010, 30:393-400. 10.1016/j.reprotox.2010.06.006
41. Cheng LJ, Cheng TS: Oxidative effects and metabolic changes following exposure of greater duckweed (Spirodela polyrhiza) to diethyl phthalate. Aquat Toxicol 2012, 109:166-75.
42. Dhir A, Kulkarni SK: Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems. Can J Physiol Pharmacol 2008, 86:726-35. 10.1139/Y08-077
43. Gupta C: Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med 2000, 224:61-8. 10.1046/j.1525-1373.2000.22402.x
44. Inagaki T, Gautreaux C, Luine V: Acute estrogen treatment facilitates recognition memory consolidation and alters monoamine levels in memory-related brain areas. Horm Behav 2010, 58:415-26. 10.1016/j.yhbeh.2010.05.013
45. Jenkins S, Wang J, Eltoum I, Desmond R, Lamartiniere CA: Chronic oral exposure to bisphenol A results in a nonmonotonic dose-response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect 2011, 119:1604-9. 10.1289/ehp.1103850
46. Jones BA, Shimell JJ, Watson NV: Pre- and postnatal bisphenol A treatment results in persistent deficits in the sexual behavior of male rats, but not female rats, in adulthood. Horm Behav 2011, 59:246-51. 10.1016/j.yhbeh.2010.12.006
47. Kohlerova E, Skarda J: Mouse bioassay to assess oestrogenic and anti-oestrogenic compounds: hydroxytamoxifen, diethylstilbestrol and genistein. J Vet Med A Physiol Pathol Clin Med 2004, 51:209-17. 10.1111/j.1439-0442.2004.00634.x
48. Li L, Andersen ME, Heber S, Zhang Q: Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression. J Mol Endocrinol 2007, 38:569-85. 10.1677/JME-07-0003
49. Love OP, Shutt LJ, Silfies JS, Bortolotti GR, Smits JE, Bird DM: Effects of dietary PCB exposure on adrenocortical function in captive American kestrels (Falco sparverius). Ecotoxicology 2003, 12:199-208. 10.1023/A:1022502826800
50. Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, Priymenko N, et al.: Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012, 55:395-407. 10.1002/hep.24685
51. Oehlmann J, Schulte-Oehlmann U, Tillmann M, Markert B: Effects of endocrine disruptors on prosobranch snails (Mollusca: Gastropoda) in the laboratory. Part I: Bisphenol A and octylphenol as xeno-estrogens. Ecotoxicology 2000, 9:383-97. 10.1023/A:1008972518019
52. Palanza P, Parmigiani S, VomSaal FS: Effects of prenatal exposure to low doses of diethylstilbestrol, o,p'DDT, and methoxychlor on postnatal growth and neurobehavioral development in male and female mice. Horm Behav 2001, 40:252-65. 10.1006/hbeh.2001.1697
53. Pelch KE, Carleton SM, Phillips CL, Nagel SC: Developmental exposure to xenoestrogens at low doses alters femur length and tensile strength in adult mice. Biol Reprod 2012, 86:69. 10.1095/biolreprod.111.096545
54. Putz O, Schwartz CB, Kim S, LeBlanc GA, Cooper RL, Prins GS: Neonatal low- and high-dose exposure to estradiol benzoate in the male rat: I. Effects on the prostate gland. Bio Reprod 2001, 65:1496-505. 10.1095/biolreprod65.5.1496
55. Putz O, Schwartz CB, LeBlanc GA, Cooper RL, Prins GS: Neonatal low- and high-dose exposure to estradiol benzoate in the male rat: II. Effects on male puberty and the reproductive tract. Biol Reprod 2001, 65:1506-17. 10.1095/biolreprod65.5.1506
56. Ribeiro AC, Pfaff DW, Devidze N: Estradiol modulates behavioral arousal and induces changes in gene expression profiles in brain regions involved in the control of vigilance. Eur J Neurosci 2009, 29:795-801. 10.1111/j.1460-9568.2009.06620.x
57. Skarda J: Sensitivity and specificity of bioassay of estrogenicity on mammary gland and uterus of female mice. Physiol Res 2002, 51:407-12.
58. Skarda J: Sensitivity and specificity of the bioassay of estrogenicity in mammary gland and seminal vesicles of male mice. Physiol Res 2002, 51:267-76.
59. Takano H, Yanagisawa R, Inoue K, Ichinose T, Sadakane K, Yoshikawa T: Di-(2-ethylhexyl) phthalate enhances atopic dermatitis-like skin lesions in mice. Environ Health Perspect 2006, 114:1266-9. 10.1289/ehp.8985
60. Vandenberg LN, Wadia PR, Schaeberle CM, Rubin BS, Sonnenschein C, Soto AM: The mammary gland response to estradiol: monotonic at the cellular level, non-monotonic at the tissue-level of organization? J Steroid Biochem Mol Biol 2006, 101:263-74. 10.1016/j.jsbmb.2006.06.028
61. Vandenberg LN, Maffini MV, Schaeberle CM, Ucci AA, Sonnenschein C, Rubin BS, et al.: Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol 2008, 26:210-9. 10.1016/j.reprotox.2008.09.015
62. vom Saal FS, Nagel SC, Palanza P, Boechler M, Parmigiani S, Welshons WV: Estrogenic pesticides: binding relative to estradiol in MCF-7 cells and effects of exposure during fetal life on subsequent territorial behaviour in male mice. Toxicol Lett 1995, 77:343 - 350. 10.1016/0378-4274(95)03316-5
63. vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, et al.: Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A 1997, 94:2056-61. 10.1073/pnas.94.5.2056
64. VomSaal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, Nagel SC, et al.: A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 1998, 14:239-60. 10.1177/074823379801400115
65. Berga S, Naftolin F: Neuroendocrine control of ovulation. Gynecol Endocrinol 2012,28(Suppl 1):9-13.
66. Costa-e-Sousa RH, Hollenberg AN: Minireview: The neural regulation of the hypothalamic-pituitary-thyroid axis. Endocrinology 2012, 153:4128-35. 10.1210/en.2012-1467
67. Bouvier M, Collins S, O'Dowd BF, Campbell PT, de Blasi A, Kobilka BK, et al.: Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem 1989, 264:16786-92.
68. Lohse MJ, Benovic JL, Caron MG, Lefkowitz RJ: Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem 1990, 265:3202-11.
69. Peyromaure M, Rebillard X, Ruffion A, Salomon L, Villers A, Soulie M, et al.: Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy. Prog Urol 2008, 18:2-8. 10.1016/j.purol.2007.10.007
70. Maness SC, McDonnell DP, Gaido KW: Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells. Toxicol Appl Pharmacol 1998, 151:135-42. 10.1006/taap.1998.8431
71. Wadia PR, Vandenberg LN, Schaeberle CM, Rubin BS, Sonnenschein C, Soto AM: Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect 2007, 115:592-8. 10.1289/ehp.9640
72. Cabaton NJ, Wadia PR, Rubin BS, Zalko D, Schaeberle CM, Askenase MH, et al.: Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ Health Perspect 2011, 119:547-52.
73. Thigpen JE, Setchell KD, Kissling GE, Locklear J, Caviness GF, Whiteside T, et al.: The estrogenic content of rodent diets, bedding, cages, and water bottles and its effect on bisphenol A studies. J Am Assoc Lab Anim Sci 2013, 52:130-41.
74. Le HH, Belcher SM: Rapid signaling actions of environmental estrogens in developing granule cell neurons Are mediated by estrogen receptor β. Endocrinology 2010, 151:5689-99. 10.1210/en.2010-0710
75. Zsarnovszky A, Le HH, Wang HS, Belcher SM: Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 2005, 146:5388-96. 10.1210/en.2005-0565
76. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, et al.: Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology 2012, 153:4097-110. 10.1210/en.2012-1422
77. Calabrese EJ, Blain R: The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol 2005, 202:289-301. 10.1016/j.taap.2004.06.023
78. Rhomberg LR, Goodman JE: Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: Has the case been made? Regul Toxicol Pharmacol 2012, 64:130-3. 10.1016/j.yrtph.2012.06.015
79. Beausoleil C, Ormsby JN, Gies A, Hass U, Heindel JJ, Holmer ML, et al.: Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere 2013, 93:847-56. 10.1016/j.chemosphere.2013.06.043
80. Barouki R, Gluckman PD, Grandjean P, Hanson M, Heindel JJ: Developmental origins of non-communicable disease: implications for research and public health. Environ Health 2012, 11:1-9. 10.1186/1476-069X-11-1
81. Hanson MA, Gluckman PD: Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol 2008, 102:90-3. 10.1111/j.1742-7843.2007.00186.x
82. Bergman A, Heindel JJ, Kasten T, Kidd KA, Jobling S, Neira M, et al.: The impact of endocrine disruption: a consensus statement on the state of the science. Environ Health Perspect 2013, 121:104-6. 10.1289/ehp.1205448
83. Kortenkamp A, Martin O, Faust M, Evans R, McKinlay R, Orton F, et al.: State of the art assessment of endocrine disrupters. [ http://ec.europa.eu/environment/chemicals/endocrine/pdf/sota-edc-final-report.pdf ]